Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor

R. J. O'Reilly, B. Dupont, Savita G Pahwa, E. Grimes, E. M. Smithwick, Rajendra Pahwa, S. Schwartz, J. A. Hansen, F. P. Siegal, M. Sorell, A. Svejgaard, C. Jersild, M. Thomsen, P. Platz, P. L'Esperance, R. A. Good

Research output: Contribution to journalArticle

127 Citations (Scopus)

Abstract

A patient with severe combined immunodeficiency received seven transplants of bone marrow from an HLA-B-compatible and HLA-D-compatible unrelated donor in an attempt to provide immunologic reconstitution. The first 4 transplants achieved restricted engraftment with evidence of rudimentary immunologic function. A fifth transplant, given after low-dose cyclophosphamide, produced reconstitution of cell-mediated immunity. Marrow aplasia developed after recontamination with a non-pathogenic microflora. Transplantation of marrow previously stored in liquid nitrogen was ineffective. A subsequent transplant, administered after high-dose cyclophosphamide, achieved durable engraftment, with complete hematopoietic and immunologic reconstitution. Seventeen months after transplantation, full functional engraftment persists. Graft-versus-host disease has been chronic and moderately severe, but limited to the skin and oral mucosa. Transplantation of marrow from unrelated histocompatible donors may provide a useful treatment for patients with severe combined immunodeficiency or aplastic anemia who lack a mtched sibling or related donor.

Original languageEnglish
Pages (from-to)1311-1318
Number of pages8
JournalNew England Journal of Medicine
Volume297
Issue number24
StatePublished - Dec 1 1977
Externally publishedYes

Fingerprint

Severe Combined Immunodeficiency
Unrelated Donors
Transplantation
Bone Marrow
Transplants
Cyclophosphamide
HLA-D Antigens
HLA-B Antigens
Aplastic Anemia
Mouth Mucosa
Graft vs Host Disease
Cellular Immunity
Siblings
Nitrogen
Tissue Donors
Skin
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

O'Reilly, R. J., Dupont, B., Pahwa, S. G., Grimes, E., Smithwick, E. M., Pahwa, R., ... Good, R. A. (1977). Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor. New England Journal of Medicine, 297(24), 1311-1318.

Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor. / O'Reilly, R. J.; Dupont, B.; Pahwa, Savita G; Grimes, E.; Smithwick, E. M.; Pahwa, Rajendra; Schwartz, S.; Hansen, J. A.; Siegal, F. P.; Sorell, M.; Svejgaard, A.; Jersild, C.; Thomsen, M.; Platz, P.; L'Esperance, P.; Good, R. A.

In: New England Journal of Medicine, Vol. 297, No. 24, 01.12.1977, p. 1311-1318.

Research output: Contribution to journalArticle

O'Reilly, RJ, Dupont, B, Pahwa, SG, Grimes, E, Smithwick, EM, Pahwa, R, Schwartz, S, Hansen, JA, Siegal, FP, Sorell, M, Svejgaard, A, Jersild, C, Thomsen, M, Platz, P, L'Esperance, P & Good, RA 1977, 'Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor', New England Journal of Medicine, vol. 297, no. 24, pp. 1311-1318.
O'Reilly, R. J. ; Dupont, B. ; Pahwa, Savita G ; Grimes, E. ; Smithwick, E. M. ; Pahwa, Rajendra ; Schwartz, S. ; Hansen, J. A. ; Siegal, F. P. ; Sorell, M. ; Svejgaard, A. ; Jersild, C. ; Thomsen, M. ; Platz, P. ; L'Esperance, P. ; Good, R. A. / Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor. In: New England Journal of Medicine. 1977 ; Vol. 297, No. 24. pp. 1311-1318.
@article{f74fec0135cc436d916678c1202fa782,
title = "Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor",
abstract = "A patient with severe combined immunodeficiency received seven transplants of bone marrow from an HLA-B-compatible and HLA-D-compatible unrelated donor in an attempt to provide immunologic reconstitution. The first 4 transplants achieved restricted engraftment with evidence of rudimentary immunologic function. A fifth transplant, given after low-dose cyclophosphamide, produced reconstitution of cell-mediated immunity. Marrow aplasia developed after recontamination with a non-pathogenic microflora. Transplantation of marrow previously stored in liquid nitrogen was ineffective. A subsequent transplant, administered after high-dose cyclophosphamide, achieved durable engraftment, with complete hematopoietic and immunologic reconstitution. Seventeen months after transplantation, full functional engraftment persists. Graft-versus-host disease has been chronic and moderately severe, but limited to the skin and oral mucosa. Transplantation of marrow from unrelated histocompatible donors may provide a useful treatment for patients with severe combined immunodeficiency or aplastic anemia who lack a mtched sibling or related donor.",
author = "O'Reilly, {R. J.} and B. Dupont and Pahwa, {Savita G} and E. Grimes and Smithwick, {E. M.} and Rajendra Pahwa and S. Schwartz and Hansen, {J. A.} and Siegal, {F. P.} and M. Sorell and A. Svejgaard and C. Jersild and M. Thomsen and P. Platz and P. L'Esperance and Good, {R. A.}",
year = "1977",
month = "12",
day = "1",
language = "English",
volume = "297",
pages = "1311--1318",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "24",

}

TY - JOUR

T1 - Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor

AU - O'Reilly, R. J.

AU - Dupont, B.

AU - Pahwa, Savita G

AU - Grimes, E.

AU - Smithwick, E. M.

AU - Pahwa, Rajendra

AU - Schwartz, S.

AU - Hansen, J. A.

AU - Siegal, F. P.

AU - Sorell, M.

AU - Svejgaard, A.

AU - Jersild, C.

AU - Thomsen, M.

AU - Platz, P.

AU - L'Esperance, P.

AU - Good, R. A.

PY - 1977/12/1

Y1 - 1977/12/1

N2 - A patient with severe combined immunodeficiency received seven transplants of bone marrow from an HLA-B-compatible and HLA-D-compatible unrelated donor in an attempt to provide immunologic reconstitution. The first 4 transplants achieved restricted engraftment with evidence of rudimentary immunologic function. A fifth transplant, given after low-dose cyclophosphamide, produced reconstitution of cell-mediated immunity. Marrow aplasia developed after recontamination with a non-pathogenic microflora. Transplantation of marrow previously stored in liquid nitrogen was ineffective. A subsequent transplant, administered after high-dose cyclophosphamide, achieved durable engraftment, with complete hematopoietic and immunologic reconstitution. Seventeen months after transplantation, full functional engraftment persists. Graft-versus-host disease has been chronic and moderately severe, but limited to the skin and oral mucosa. Transplantation of marrow from unrelated histocompatible donors may provide a useful treatment for patients with severe combined immunodeficiency or aplastic anemia who lack a mtched sibling or related donor.

AB - A patient with severe combined immunodeficiency received seven transplants of bone marrow from an HLA-B-compatible and HLA-D-compatible unrelated donor in an attempt to provide immunologic reconstitution. The first 4 transplants achieved restricted engraftment with evidence of rudimentary immunologic function. A fifth transplant, given after low-dose cyclophosphamide, produced reconstitution of cell-mediated immunity. Marrow aplasia developed after recontamination with a non-pathogenic microflora. Transplantation of marrow previously stored in liquid nitrogen was ineffective. A subsequent transplant, administered after high-dose cyclophosphamide, achieved durable engraftment, with complete hematopoietic and immunologic reconstitution. Seventeen months after transplantation, full functional engraftment persists. Graft-versus-host disease has been chronic and moderately severe, but limited to the skin and oral mucosa. Transplantation of marrow from unrelated histocompatible donors may provide a useful treatment for patients with severe combined immunodeficiency or aplastic anemia who lack a mtched sibling or related donor.

UR - http://www.scopus.com/inward/record.url?scp=0017697285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017697285&partnerID=8YFLogxK

M3 - Article

C2 - 21351

AN - SCOPUS:0017697285

VL - 297

SP - 1311

EP - 1318

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 24

ER -